Nav: Home

Anti-tumor effect of novel plasma medicine caused by lactate

December 13, 2016

Nagoya, Japan - Physical plasma is one of the four fundamental states of matter, together with solid, liquid, and gas, and can be completely or partially ionized (thermal/hot or non-thermal/cold plasma, respectively). Non-thermal plasma has many industrial applications, but plasma medicine is a new field of therapy based on non-thermal atmospheric pressure plasma that has been used in cancer treatment, wound healing, and blood coagulation. Plasma is known to react with air to produce highly reactive free radicals, and with liquid to produce long-lived reactive molecules that can be used for chemotherapy. However, the exact components responsible for the anti-tumor effects were unknown.

Now, a research team based at Nagoya University used plasma to activate Ringer's solution, a salt solution with existing therapeutic functions, and showed that its lactate component had anti-tumor effects. The study was reported in Scientific Reports.

Previous work by the researchers developed plasma-activated cell culture medium as a form of chemotherapy, but selected Ringer's solution in the present work because of its simpler composition and likelihood of forming less complex reaction products. Ringer's lactate solution (Lactec) was irradiated with plasma for 3-5 minutes, after which it demonstrated anti-tumor effects on brain tumor cells.

Other plasma-activated solutions have previously been shown to induce reactive oxygen species within cells, but these were not detected in plasma-activated Lactec (PAL)-treated cells, suggesting an alternative mechanism triggered cell death. Analysis of PAL identified high levels of hydrogen peroxide, which is a known anti-tumor factor and the probable cause of cell death.

Lactec contains lactate and the salts sodium chloride, calcium chloride, and potassium chloride, in addition to water, so the team systematically analyzed plasma-activated synthetic versions of each component to identify which was responsible for killing cancer cells. "Only lactate demonstrated anti-tumor properties and generated hydrogen peroxide following plasma irradiation," first author Hiromasa Tanaka says. "This indicates that activated lactate increases intracellular hydrogen peroxide levels which cause apoptosis of the tumor cells."

Some cell types were not killed by treatment with PAL, suggesting it could be used as a specific tumor therapy. "PAL also appears to be safe for use in vivo," corresponding author Kae Nakamura says, "as we observed no adverse effects when PAL successfully reduced the tumor volume of mice."
-end-
The article "Non-thermal atmospheric pressure plasma activates lactate in Ringer's solution for anti-tumor effects" was published in the Nature journal Scientific Reports at DOI: 10.1038/srep36282

Nagoya University

Related Chemotherapy Articles:

Chemotherapy drug may increase vulnerability to depression
A chemotherapy drug used to treat brain cancer may increase vulnerability to depression by stopping new brain cells from growing, according to a new King's College London study out today in Translational Psychiatry.
Sperm changes documented years after chemotherapy
A Washington State University researcher has documented epigenetic changes in the sperm of men who underwent chemotherapy in their teens.
Depressed patients are less responsive to chemotherapy
A brain-boosting protein plays an important role in how well people respond to chemotherapy, researchers report at the ESMO Asia 2016 Congress in Singapore.
Breast cancer study predicts better response to chemotherapy
It is known from previous research that the ER-beta estrogen receptor often has a protective effect.
Personalizing chemotherapy to treat pediatric leukemia
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.
How gut microbes help chemotherapy drugs
Two bacterial species that inhabit the human gut activate immune cells to boost the effectiveness of a commonly prescribed anticancer drug, researchers report Oct.
Molecule prevents effect of chemotherapy
For the last three years the research team has been working on the development of a so-called biomarker to predict treatment effectiveness.
Study provides new clues to leukemia resurgence after chemotherapy
For the first time, researchers have discovered that some leukemia cells harvest energy resources from normal cells during chemotherapy, helping the cancer cells not only to survive, but actually thrive, after treatment.
Dialing up chemotherapy for pancreatic cancer with ultrasound
Researchers at Haukeland University Hospital in Bergen, Norway have combined a laboratory ultrasound technique called 'sonoporation' with the commercially-available chemotherapy compound Gemcitabine to increase the porosity of pancreatic cells with microbubbles and to help get the drug into cancer cells where it is needed.
Vitamin A may help improve pancreatic cancer chemotherapy
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in treating pancreatic cancer, according to an early study by Queen Mary University of London.

Related Chemotherapy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...